Shopping Cart
- Remove All
Your shopping cart is currently empty
9-ING-41 is a glycogen synthase kinase-3 inhibitor.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $45 | In Stock | |
| 2 mg | $64 | In Stock | |
| 5 mg | $101 | In Stock | |
| 10 mg | $166 | In Stock | |
| 25 mg | $343 | In Stock | |
| 50 mg | $497 | In Stock | |
| 100 mg | $742 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $118 | In Stock |
| Description | 9-ING-41 is a glycogen synthase kinase-3 inhibitor. |
| Targets&IC50 | GSK-3β:0.71 μM (IC50) |
| In vitro | 9-ING-41 (2, 4 μM; 48 hours) decreases neuroblastoma cell viability induces apoptosis[2]. 9-ING-41 (1, 2 μM; 24 hours) is a potent cell cycle-blocking agent for lymphoma cells[2]. 9-ING-41 (0.1-1 μM) inhibits GSK-3 leading to a decreased expression of the NF-κB target XIAP and significant apoptosis in neuroblastoma cells as shown by PARP cleavage, an apoptosis marker[1]. 9-ING-41 (0.5, 1.0, 1.5, 2.0 μM) inhibits the proliferation rate of all TCL and MCL lines with concentrations as low as 1.0 mM[2]. |
| In vivo | In a mouse model of MCL, 9-ING-41 (40 mg/kg/every other day; for 17 days) has single-agent antitumor activity [2]. |
| Molecular Weight | 404.35 |
| Formula | C22H13FN2O5 |
| Cas No. | 1034895-42-5 |
| Smiles | Cn1cc(C2=C(C(=O)NC2=O)c2coc3ccc(F)cc23)c2cc3OCOc3cc12 |
| Relative Density. | 1.63 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 97 mg/mL (239.89 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.